Clinical Trial Update: Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trials of the probiotic Bifidobacterium Infantis M-63 show improvements in mental health symptoms in irritable bowel syndrome patients following a maj…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome
• Small Intestinal Bacterial Overgrowth

Drugs mentioned

• Bifidobacterium Infantis M-63

Snippet

Sponsor: Universiti Sains Malaysia | Conditions: Irritable Bowel Syndrome, Abdominal Pain | Phase 2, Phase 3 | Status: COMPLETED